172 related articles for article (PubMed ID: 8910759)
21. Pharmacodynamics of biological response in vivo after single and multiple doses of interferon-beta.
Witt PL; Storer BE; Bryan GT; Brown RR; Flashner M; Larocca AT; Colby CB; Borden EC
J Immunother Emphasis Tumor Immunol; 1993 Apr; 13(3):191-200. PubMed ID: 8471593
[TBL] [Abstract][Full Text] [Related]
22. Serum interferon level and (2'-5')oligoadenylate synthetase activity in lymphocytes during clinical interferon application.
Lodemann E; Nitsche EM; Lang MH; Gerein V; Altmeyer P; Holzmann H; Kornhuber B
J Interferon Res; 1985; 5(4):621-8. PubMed ID: 2418131
[TBL] [Abstract][Full Text] [Related]
23. Comparative study of the pharmacodynamic and pharmacologic effects of Betaseron and AVONEX.
Williams GJ; Witt PL
J Interferon Cytokine Res; 1998 Nov; 18(11):967-75. PubMed ID: 9858319
[TBL] [Abstract][Full Text] [Related]
24. Safety, pharmacokinetics and pharmacodynamics of recombinant human tumour necrosis factor-binding protein-1 (Onercept) injected by intravenous, intramuscular and subcutaneous routes into healthy volunteers.
Trinchard-Lugan I; Ho-Nguyen Q; Bilham WM; Buraglio M; Ythier A; Munafo A
Eur Cytokine Netw; 2001; 12(3):391-8. PubMed ID: 11566619
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and pharmacodynamics of PEGylated IFN-beta 1a following subcutaneous administration in monkeys.
Mager DE; Neuteboom B; Jusko WJ
Pharm Res; 2005 Jan; 22(1):58-61. PubMed ID: 15771230
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of recombinant human interferon-beta ser in healthy volunteers and its effect on serum neopterin.
Chiang J; Gloff CA; Yoshizawa CN; Williams GJ
Pharm Res; 1993 Apr; 10(4):567-72. PubMed ID: 8483840
[TBL] [Abstract][Full Text] [Related]
27. Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markers.
Rothuizen LE; Buclin T; Spertini F; Trinchard I; Munafo A; Buchwalder PA; Ythier A; Biollaz J
J Neuroimmunol; 1999 Sep; 99(1):131-41. PubMed ID: 10496186
[TBL] [Abstract][Full Text] [Related]
28. Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta-1a after intramuscular and subcutaneous administration.
Munafo A; Trinchard-Lugan I; Nguyen TX; Buraglio M
Eur J Neurol; 1998 Mar; 5(2):187-193. PubMed ID: 10210831
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic and pharmacodynamic studies of a human serum albumin-interferon-alpha fusion protein in cynomolgus monkeys.
Osborn BL; Olsen HS; Nardelli B; Murray JH; Zhou JX; Garcia A; Moody G; Zaritskaya LS; Sung C
J Pharmacol Exp Ther; 2002 Nov; 303(2):540-8. PubMed ID: 12388634
[TBL] [Abstract][Full Text] [Related]
30. Clinical pharmacology of recombinant human luteinizing hormone: Part II. Bioavailability of recombinant human luteinizing hormone assessed with an immunoassay and an in vitro bioassay.
le Cotonnec JY; Porchet HC; Beltrami V; Munafo A
Fertil Steril; 1998 Feb; 69(2):195-200. PubMed ID: 9496328
[TBL] [Abstract][Full Text] [Related]
31. Biological and clinical effects of interferon-beta ser at two doses.
Borden EC; Rinehart JJ; Storer BE; Trump DL; Paulnock DM; Teitelbaum AP
J Interferon Res; 1990 Dec; 10(6):559-70. PubMed ID: 2086672
[TBL] [Abstract][Full Text] [Related]
32. Comparative pharmacokinetics and pharmacodynamics of two recombinant human interferon beta 1a (IFN beta-1a) products administered intramuscularly in healthy male and female volunteers.
Borden EC
Pharm Res; 1998 Jan; 15(1):2-3. PubMed ID: 9487538
[No Abstract] [Full Text] [Related]
33. Comparative pharmacokinetics and pharmacodynamics of two recombinant human interferon beta 1a (IFN beta-1a) products administered intramuscularly in healthy male and female volunteers.
Fumero S
Pharm Res; 1998 Jan; 15(1):1. PubMed ID: 9487537
[No Abstract] [Full Text] [Related]
34. Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration.
Khan OA; Xia Q; Bever CT; Johnson KP; Panitch HS; Dhib-Jalbut SS
Neurology; 1996 Jun; 46(6):1639-43. PubMed ID: 8649563
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic and pharmacodynamic characterization of a novel formulation containing co-formulated interferons alpha-2b and gamma in healthy male volunteers.
García-García I; Hernández-González I; Díaz-Machado A; González-Delgado CA; Pérez-Rodríguez S; García-Vega Y; Campos-Mojena R; Tuero-Iglesias ÁD; Valenzuela-Silva CM; Cruz-Ramírez A; Martín-Trujillo A; Santana-Milián H; López-Saura PA; Bello-Rivero I;
BMC Pharmacol Toxicol; 2016 Dec; 17(1):58. PubMed ID: 27923408
[TBL] [Abstract][Full Text] [Related]
36. Serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis B.
Shindo M; Okuno T; Matsumoto M; Takeda M; Takino T; Sokawa J; Iwata A; Sokawa Y
Hepatology; 1988; 8(2):366-70. PubMed ID: 2451634
[TBL] [Abstract][Full Text] [Related]
37. In vivo pharmacology and toxicology evaluation of polyethylene glycol-conjugated interferon beta-1a.
Hu X; Olivier K; Polack E; Crossman M; Zokowski K; Gronke RS; Parker S; Li Z; Nestorov I; Baker DP; Clarke J; Subramanyam M
J Pharmacol Exp Ther; 2011 Sep; 338(3):984-96. PubMed ID: 21690216
[TBL] [Abstract][Full Text] [Related]
38. Phase I/II trial of interferon-beta-serine in patients with renal cell carcinoma: immunological and biological effects.
Rinehart JJ; Young D; Laforge J; Colborn D; Neidhart JA
Cancer Res; 1987 May; 47(9):2481-5. PubMed ID: 3567933
[TBL] [Abstract][Full Text] [Related]
39. Variation in the binding of 125I-labeled interferon-beta ser to cellular receptors during growth of human renal and bladder carcinoma cells in vitro.
Ruzicka FJ; Schmid SM; Groveman DS; Cummings KB; Borden EC
Cancer Res; 1987 Sep; 47(17):4582-9. PubMed ID: 2957045
[TBL] [Abstract][Full Text] [Related]
40. Tolerability and pharmacokinetic properties of ondansetron administered subcutaneously with recombinant human hyaluronidase in minipigs and healthy volunteers.
Dychter SS; Harrigan R; Bahn JD; Printz MA; Sugarman BJ; DeNoia E; Haughey DB; Fellows D; Maneval DC
Clin Ther; 2014 Feb; 36(2):211-24. PubMed ID: 24486335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
